ラクオリア創薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4579/E25269 | RaQualia Pharma Inc. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/04/24 | 日証協 | 689,700株 | -1.93% | 8,200株 | +331.58% | 525,036株 | -1.94% | 920株 | +2.22% |
2015/04/17 | 日証協 | 703,300株 | -1.88% | 1,900株 | -45.71% | 535,436株 | -1.09% | 900株 | -85.71% |
2015/04/10 | 日証協 | 716,800株 | +0.08% | 3,500株 | -94.68% | 541,336株 | -0.24% | 6,300株 | -69.71% |
2015/04/03 | 日証協 | 716,200株 | -10% | 65,800株 | +134.16% | 542,636株 | -7.59% | 20,800株 | -32.95% |
2015/03/20 | 日証協 | 773,100株 | +3.84% | 70,300株 | +266.15% | 577,416株 | -0.53% | 52,600株 | +248.34% |
2015/03/13 | 日証協 | 744,500株 | -0.45% | 19,200株 | -0.52% | 580,516株 | +0.33% | 15,100株 | +439.29% |
2015/03/06 | 日証協 | 747,900株 | -1.79% | 19,300株 | -73.04% | 578,616株 | -7.9% | 2,800株 | -87.1% |
2015/02/27 | 日証協 | 761,500株 | +6.71% | 71,600株 | +2.29% | 628,216株 | +6.2% | 21,700株 | -54.79% |
2015/02/20 | 日証協 | 713,600株 | +0.68% | 70,000株 | +9999.99% | 591,516株 | +0.42% | 48,000株 | +616.42% |
2015/02/13 | 日証協 | 708,800株 | -1.46% | 89株 | -98.15% | 589,016株 | -0.85% | 6,700株 | -48.58% |
2015/02/06 | 日証協 | 719,311株 | -2.62% | 4,800株 | -80.49% | 594,076株 | -0.63% | 13,029株 | +97.41% |
2015/01/30 | 日証協 | 738,700株 | -3.46% | 24,600株 | +2.93% | 597,821株 | -3.7% | 6,600株 | -38.32% |
2015/01/23 | 日証協 | 765,200株 | +2.55% | 23,900株 | +48.45% | 620,821株 | +1.09% | 10,700株 | -0.93% |
2015/01/16 | 日証協 | 746,200株 | +1.02% | 16,100株 | +103.8% | 614,121株 | +1.29% | 10,800株 | +25.58% |
2015/01/09 | 日証協 | 738,700株 | -1.96% | 7,900株 | -51.53% | 606,321株 | +2.35% | 8,600株 | -69.65% |
2014/12/30 | 日証協 | 753,500株 | +2.73% | 16,300株 | -71.99% | 592,381株 | +4.11% | 28,340株 | -55.93% |
2014/12/26 | 日証協 | 733,500株 | +2.12% | 58,200株 | -18.03% | 569,021株 | +2.65% | 64,300株 | +46.14% |
2014/12/19 | 日証協 | 718,300株 | +6.38% | 71,000株 | -15.78% | 554,321株 | +7.07% | 44,000株 | +118.89% |
2014/12/12 | 日証協 | 675,200株 | -4.89% | 84,300株 | +633.04% | 517,721株 | -0.99% | 20,101株 | +276.56% |
※株式分割は考慮していませんのでご注意ください。
Page Top